Highly uniform spherical pellets with excellent flowability for reliable high-speed tablet compression.
Optimized particle size distribution (D50 ≈ 350–450 µm) enabling superior die-fill consistency and reduced weight variation.
Low moisture content (< 5.0%) ensures enhanced stability during storage and compatibility with moisture-sensitive APIs.
Pharmaceutical-grade purity compliant with USP/NF, EP, and JP monographs for microcrystalline cellulose.
Consistent compressibility and binding performance across batches, supporting robust formulation development and scale-up.
Direct compression tablet cores for oral solid dosage forms in human pharmaceuticals.
Core material for film-coated and enteric-coated immediate-release tablets.
Carrier matrix in controlled-release multiparticulate systems (e.g., pelletization via extrusion-spheronization).
Excipient in nutraceutical tablets requiring high-density, low-dust pellet morphology.
Base core for layered or coated extended-release drug delivery platforms.
| Chemical Type | Microcrystalline cellulose (MCC) |
| Product Form | Spherical pellets |
| Appearance | White to off-white free-flowing granular powder |
| Primary Applications | Pharmaceutical direct compression and pellet core substrate |
| Key Features | High flowability, low dust generation, excellent compressibility |
| Compliance | USP/NF, Ph. Eur., JP, and FDA GRAS listed |
| Moisture Content | ≤ 5.0% (w/w) |
| Residue on Ignition | ≤ 0.5% (w/w) |
Contact With Us:
E-mail: wangxingqiang@ericwchem.com
Have a Questions? Call Us:
Add:
Building A1, Jiete Industrial Park, Huangpu District, Guangzhou City, Guangdong Province, China